Clinical Trial Detail

NCT ID NCT03869190
Title A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-based Treatment Combinations in Patients With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy (MORPHEUS mUC)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

urethra transitional cell carcinoma

Therapies

Atezolizumab + Tocilizumab

Atezolizumab + Niraparib

Atezolizumab + Hu5F9-G4

Atezolizumab + Enfortumab vedotin-ejfv

Atezolizumab + Linagliptin

Atezolizumab + Isatuximab

Atezolizumab

Age Groups: adult senior

No variant requirements are available.